GeneCentric Therapeutics

About GeneCentric Therapeutics

GeneCentric is a company focused on translating the complexity of tumor biology into actionable insights for precision oncology. Their mission is to advance cancer genomic profiling and deliver innovative solutions through gene expression and liquid biopsy technologies to fight cancer.

Products & Services

PurIST(r) Test:A test for pancreatic cancer, now commercially available.

GenomicsNext™:A liquid biopsy platform that integrates high-fidelity detection of DNA alterations and gene expression, providing a comprehensive precision medicine solution for cancer profiling.

Specialties

Gene Expression Technology Liquid Biopsy Cancer Genomic Profiling Precision Medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 8000000 MR: - FA: $8.0 million FAN: 8000000	D: 2025-06-18 FD: 2025-06-18	4 investors

Series C Latest

2025-06-18

$8.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael V. Milburn

Chief Executive Officer and President

K

Kirk Beebe

Chief Scientific Officer

C

Chenyqua Shepard

Chief Operating Officer

M

Myla Lai-Goldman

Founder & Executive Chairperson

A

Arnold J. Levine

Director

C

Charles M. Perou

Founder and Director

View 9 more team members with Pro

Unlock Full Team Directory

Recent News